Maculaser Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 11

Maculaser General Information

Description

Developer of novel laser therapy technology designed to prevent blindness by targeting major retinal diseases. The company's technology builds electroretinography signals to control laser-induced retinal heating to treat common retinal disorders, which can be diagnosed at an early phase in a personalized and safe manner, enabling clinicians to perform previously infeasible laser therapy and control the retinal pigment epithelium layer to battle degenerative changes in the eye.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Keilaranta 1
  • 02150 Espoo
  • Finland
+358 045
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Therapeutic Devices
Corporate Office
  • Keilaranta 1
  • 02150 Espoo
  • Finland
+358 045

Maculaser Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Maculaser Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 28-May-2026 Completed Clinical Trials - General
9. Accelerator/Incubator 29-Sep-2023 Completed Clinical Trials - General
8. Later Stage VC 12-Dec-2022 Completed Generating Revenue
7. Accelerator/Incubator 01-Jan-2022 Completed Clinical Trials - General
6. Early Stage VC 02-Sep-2021 Completed Clinical Trials - General
5. Accelerator/Incubator 08-Jun-2020 Completed Startup
4. Early Stage VC 01-Jan-2020 Completed Startup
3. Accelerator/Incubator 01-Jan-2018 Completed Startup
2. Accelerator/Incubator 01-Jan-2018 Completed Startup
1. University Spin-Out 01-Jan-2018 Completed Startup
To view Maculaser’s complete valuation and funding history, request access »

Maculaser Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view Maculaser’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Maculaser Patents

Maculaser Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4362802-A1 A device for obtaining erg signals with related arrangement and method Pending 28-Jun-2021
US-20240382139-A1 A device for obtaining erg signals with related arrangement and method Pending 28-Jun-2021
WO-2023275440-A1 A device for obtaining erg signals with related arrangement and method Inactive 28-Jun-2021
EP-4210555-A1 An arrangement for obtaining erg signals during retinal heating and controlling retinal heating based thereon Active 10-Sep-2020
EP-4210555-A4 An arrangement for obtaining erg signals during retinal heating and controlling retinal heating based thereon Active 10-Sep-2020 A61B5/398
To view Maculaser’s complete patent history, request access »

Maculaser Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Maculaser Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
M2Care VC-Backed Company Minority
ZEISS Ventures Corporate Venture Capital Minority
Metsola Ventures Venture Capital Minority
Nordic Mentor Network For Entrepreneurship Accelerator/Incubator
Innovestor Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Maculaser FAQs

  • When was Maculaser founded?

    Maculaser was founded in 2018.

  • Where is Maculaser headquartered?

    Maculaser is headquartered in Espoo, Finland.

  • What is the size of Maculaser?

    Maculaser has 5 total employees.

  • What industry is Maculaser in?

    Maculaser’s primary industry is Diagnostic Equipment.

  • Is Maculaser a private or public company?

    Maculaser is a Private company.

  • What is Maculaser’s current revenue?

    The current revenue for Maculaser is .

  • How much funding has Maculaser raised over time?

    Maculaser has raised $3.33M.

  • Who are Maculaser’s investors?

    M2Care, ZEISS Ventures, Metsola Ventures, Nordic Mentor Network For Entrepreneurship, and Innovestor are 5 of 11 investors who have invested in Maculaser.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process